%20(1).webp)
Every doctor eventually reaches the same fork in the road: general competence has been achieved, and now it's time to decide where to specialise further. The problem is rarely a shortage of options. Between royal college pathways, CPD-certified short courses, diploma programmes, and single-day intensives, there are usually more specialty courses available in any given field than any one doctor has time or budget to complete. The harder problem is picking the right one, at the right time, for the right reasons.
This guide sets out a practical decision framework for choosing a medical specialty course, one that applies whether you're weighing up neurodevelopmental training, a procedural skill, or a purely cognitive specialty like palliative medicine. Rather than ranking specific providers, it focuses on the questions that actually predict whether a course will change what you can offer patients, versus one that will simply sit as a certificate you never quite use.
Throughout, we'll use ADHD and neurodevelopmental training as a worked example, since it's a specialty area where the decision-making stakes are unusually clear: demand has surged, the diagnostic tools are highly specific, and the gap between a superficial course and a genuinely competence-building one matters enormously for patient safety. Global ADHD Network's course pathway, covering diagnosis, management, and related specialist certifications, will come up repeatedly as a concrete illustration of how the framework applies in practice.
By the end, you should be able to look at any specialty course, in any field, and quickly judge whether it earns your time, your money, and your CPD hours.
On paper, choosing a specialty course looks like a simple comparison exercise: check the price, check the reviews, check the dates, book it. In practice, doctors get this wrong more often than the simplicity of the task would suggest, usually because the real decision isn't about the course at all. It's about matching training to a clinical and career need that many doctors haven't actually defined clearly before they start browsing course listings.
Consider how differently the "right course" question resolves for two doctors in superficially similar positions. A GP who already sees three or four suspected adult ADHD cases a month needs training that builds fast, defensible diagnostic competence, ideally within weeks, because the clinical need already exists. A GP who is merely curious about neurodevelopmental medicine as a future interest has a very different set of priorities, and might reasonably prioritise a lighter, exploratory course before committing to a full diagnostic pathway. The course that's right for one is not automatically right for the other, even though both might search for exactly the same course title.
This is compounded by how specialty training is marketed. Course pages tend to emphasise CPD hours, testimonial counts, and price, because those are the details that are easy to compare at a glance. What they rarely make easy to compare is the thing that actually determines whether training translates into competence: how much of the course is genuinely applied, hands-on skill-building against a specific clinical tool, versus how much is general background reading delivered as a lecture.
The financial and reputational cost of getting this wrong is real. A doctor who completes a superficial course and then finds themselves under-confident, or worse, formally under-qualified, when an indemnity provider or regulator asks pointed questions about training, has lost the course fee, the time invested, and possibly a period of restricted practice while they backfill the gap properly. A structured decision process at the outset avoids most of that risk.
There's also a slower, less visible cost worth naming: the opportunity cost of choosing a weak course over a strong one. Every specialty area has a finite number of hours a doctor can realistically dedicate to CPD in a given year, and time spent on a course that fails to build genuine competence is time that could have gone toward training that actually changes what a clinician can offer patients. Multiplied across a career, doctors who consistently apply a rigorous selection process end up with a meaningfully deeper, more defensible set of specialty skills than those who choose courses more casually, even if both groups attend a similar number of training days over the years.
The single most useful exercise before browsing any course listing is an honest audit of what you're actually being asked to do, or want to be asked to do, in clinic. This sounds obvious, but it's the step most doctors skip, jumping straight to comparing course options instead.
Start by counting. How many referrals or presentations related to this specialty area have you seen in the last three months? Are they growing, stable, or occasional? A GP fielding a steady trickle of adult ADHD assessment requests has a fundamentally different training need than one who has seen two such cases in the past year. The former justifies a full diagnostic and management pathway; the latter might be better served by a shorter awareness-level course, with a referral pathway to a specialist colleague for anything more complex.
Next, separate diagnosis-type needs from management-type needs, since these frequently require different training even within the same specialty. In ADHD specifically, the skill of diagnosing adult ADHD using a structured interview like DIVA-5 is largely distinct from the skill of safely titrating and monitoring stimulant medication over months or years. A clinician might need one, both, or neither, depending on whether they're the first point of contact, the ongoing prescriber, or purely a referrer. Global ADHD Network's separation of its Diagnosis Course from its Management Course reflects exactly this distinction, and choosing between them, or taking both, should be driven by which side of the pathway you actually handle.
Finally, be honest about where the caseload is heading, not just where it currently sits. Referral patterns in several specialties, neurodevelopmental medicine prominent among them, have shifted meaningfully over the past five years, and training decisions made purely on last year's caseload can leave a clinician playing catch-up just as demand accelerates.
Once you know what you need, the next filter is whether a given course actually delivers current, accredited, guideline-aligned content, rather than simply carrying a CPD label.
Accreditation itself has layers worth understanding. A generic CPD certificate confirms that a course meets basic structural standards for continuing education, but it says nothing about whether the clinical content is current or specific to your regulatory environment. What matters more is whether the course is explicitly built around the guideline your practice is actually held to. In the UK, that means checking whether a course reflects the current version of the relevant NICE guideline, NG87 for ADHD being a clear example, since guidance on first-line medication choices and monitoring intervals has shifted meaningfully in recent revisions.
This matters practically in two ways. First, a course that hasn't been updated to reflect the current guideline risks certifying you in slightly outdated practice, which is a genuine clinical risk, not just an administrative one. Second, the GMC's guidance on continuing professional development is explicit that CPD activity should be relevant to your current or emerging scope of practice, so a course that's accredited but generic carries less weight at appraisal than one that maps precisely onto a defined clinical need.
It's also worth checking who actually built the course content. Courses developed and delivered by practising specialists in the relevant field, rather than generalist CPD content producers, tend to reflect the messier reality of real clinical presentations more accurately than content built primarily to satisfy an accreditation checklist.
This is the step doctors most often skip, and it's arguably the most important one. Two courses can carry identical CPD hours and identical accreditation while differing enormously in how much genuine skill-building time they include.
A useful test: ask, or check the course syllabus for, how much time is spent on supervised, hands-on practice with the actual tools or techniques you'll use in clinic, versus how much time is spent on background theory delivered as a lecture. In ADHD diagnosis training specifically, this distinction is stark. A course that describes the DIVA-5 structured interview in a slide deck teaches you what the tool is. A course that gives you supervised practice actually administering sections of the interview, asking follow-up questions, and interpreting ambiguous answers, teaches you to use it. Only the second genuinely builds diagnostic competence.
This is why interactive breakout sessions and case-based practice, features built into courses like Global ADHD Network's Diagnosis Course, matter more than they might initially appear to on a course outline. The same principle applies well beyond neurodevelopmental medicine. A procedural specialty course is close to worthless without supervised hands-on practice and a defined competency threshold before certification. Even a purely cognitive specialty, such as palliative care communication skills, benefits enormously from role-played, feedback-driven practice rather than lecture content alone, since the skill being taught is fundamentally behavioural.
When comparing two courses of similar cost and length, the one with more visible, structured applied practice time is almost always the better investment, even if its marketing page looks less polished than a competitor's.
CPD hours matter for revalidation, but not all CPD hours are treated equally at appraisal, and doctors sometimes assume a course "counts" without checking the specifics.
Most UK royal colleges and employers recommend doctors accumulate around 50 CPD credits per year, working out to roughly 250 across a standard five-year revalidation cycle, with the GMC requiring CPD to be genuinely relevant to your current or developing scope of practice. A course that states its CPD hour allocation transparently upfront, and explains what those hours cover, gives you far stronger material to present at appraisal than one where the CPD claim is vague or unverifiable. Global ADHD Network's combined Diagnosis and Management pathway, for example, states clearly that it carries up to 16 CPD-certified hours, which is the kind of specific, documentable detail that strengthens an appraisal conversation considerably more than a generic "CPD certified" label.
It's also worth checking whether CPD hours from a course map onto any specific college or specialty CPD scheme you're part of, since some royal colleges operate their own point systems alongside general CPD requirements. A course that's accredited generically but doesn't map cleanly onto your specific college's scheme may still be valuable clinically, but it's worth knowing that distinction before assuming the hours will slot in automatically.
This step is frequently overlooked until it becomes a problem, usually right when a clinician is trying to expand into a new area of practice and discovers their indemnity provider wants specific documentation they don't have.
Medical defence organisations and insurers increasingly ask pointed questions about training completed before confirming or extending cover for specialty work, particularly in areas involving structured diagnostic tools, controlled medication prescribing, or procedures with defined complication risks. In ADHD specifically, this shows up as indemnity providers wanting to see documented competency in structured tools like DIVA-5 before covering independent assessment work, not just a general CPD certificate stating the topic was covered.
The practical lesson is to check with your specific indemnity provider before enrolling in a course, not after, if the course is meant to unlock new clinical work rather than simply refresh existing knowledge. Ask directly what documentation they expect: is a CPD certificate sufficient, or do they want evidence of a named, validated instrument being covered specifically? This single phone call or email can save a great deal of wasted course spend if the answer turns out to be more specific than the course you were considering can provide.
Price comparison is the easiest part of choosing a course and, ironically, the least useful on its own. A course priced significantly below comparable options in the same specialty has usually cut something to get there, most often supervised practice time, faculty availability for questions, or post-course support.
A more useful framework is to ask what you're getting per hour of genuine skill-building, not per hour of total course length. A single-day course with six hours of supervised, tool-specific practice is a stronger investment than a two-day course with the same six hours of practice padded out with additional lecture content, even if the per-day price of the shorter course looks higher at first glance.
It's also worth factoring in what happens after the course ends. Providers that offer ongoing access to resources, a professional network, or a route to ask follow-up clinical questions extend the value of the course well beyond the day itself. Global ADHD Network's referrals network and ongoing resource library, for instance, are the kind of post-course support that meaningfully changes the total value proposition of a course fee, compared with a provider that hands over a certificate and nothing else.
Testimonials are the most honest signal available to you before enrolling, provided you read them with the right filter. The most useful reviews come from clinicians in a similar role to yours, since a course that works brilliantly for an experienced consultant psychiatrist may land very differently for a GP with no prior specialty exposure, and vice versa.
Look specifically for reviews that mention the practical, applied elements of a course, not just general satisfaction. A review that says a course "gave me confidence to use the DIVA-5 tool in my own clinic" tells you far more than one that simply says "great course, would recommend." Volume matters too, to a point: a provider with a genuinely large, verifiable body of reviews, such as Global ADHD Network's 1,150-plus published reviews spanning doctors, nurses, psychologists, and pharmacists, gives you a much more reliable statistical picture than a handful of curated testimonials on a marketing page.
Where possible, it's also worth asking colleagues directly, particularly anyone in your existing professional network who has completed specialty training in the area you're considering. A five-minute conversation with someone who did the exact course you're weighing up is often worth more than an hour of reading marketing copy.
It's worth walking through how this entire framework applies to a specific, live decision: a doctor considering whether, and how, to move into adult ADHD assessment and treatment.
Step one, the caseload audit, usually reveals one of three positions. Some doctors are already fielding regular ADHD-related referral requests and need training urgently. Others see it occasionally and want defensible competence to handle those cases well rather than always referring out. A smaller group is exploring the specialty from a standing start, drawn by the scale of current unmet demand, CDC data putting current ADHD diagnosis at roughly 6.0% of US adults, around 15.5 million people, with more than half of those diagnoses made in adulthood rather than childhood.
Step two directs attention toward guideline alignment. In the UK, that means confirming a course reflects the current NICE NG87 guidance on diagnosis and management, including its position on first-line stimulant medications and monitoring intervals. Step three is where the real differentiation happens: does the course build genuine DIVA-5 competency through supervised, interactive practice, such as the breakout sessions built into Global ADHD Network's Diagnosis Course, or does it merely describe the tool?
Steps four and five bring appraisal and indemnity into focus. A course stating its CPD hours clearly, up to 16 across the combined Diagnosis and Management pathway, gives stronger appraisal evidence than a vague claim, and confirming with your indemnity provider that DIVA-5-specific training satisfies their requirements avoids an unpleasant surprise later. Step six weighs the roughly £795 starting price of a diagnosis-focused course, and the higher fees for combined management training, against the depth of supervised practice and the CPD hours awarded, rather than against unrelated, cheaper alternatives that may offer far less hands-on skill-building. Step seven closes the loop by checking testimonials from doctors, nurses, psychologists, and pharmacists who've completed the specific course, looking for mentions of practical confidence gained, not just general satisfaction.
The resulting decision, for a doctor who has genuinely audited their caseload and finds real demand, is usually to pursue the full combined pathway: Diagnosis Course first, since assessment is typically the first clinical touchpoint, then the Management Course once ready to take on prescribing directly, with add-ons like the ADHD in Women course or co-occurring autism certification layered in as the caseload and confidence grow.
A handful of warning signs recur across specialty course marketing, regardless of the specific field, and are worth treating as reasons to dig deeper before enrolling.
Vague accreditation claims. "CPD certified" without naming the certifying body, or without stating how many hours are awarded, is a weaker claim than it sounds. Ask directly, and treat evasiveness as a signal.
No mention of guideline currency. A course that doesn't reference which version of the relevant national guideline it's built around, or when it was last updated, may be teaching content that's several years out of date without saying so.
Testimonials with no detail. A page full of one-line "great course" reviews, with no specifics about what participants actually learned to do, is weaker evidence than a smaller number of detailed reviews describing specific clinical gains.
No visible breakdown of course time. If a provider can't or won't tell you how much of the day is supervised practice versus lecture, assume the ratio favours lecture, since that's the cheaper format to deliver.
Pressure to book immediately. Urgency tactics, limited-time discounts, artificially scarce places, are more common in weaker course marketing than in genuinely oversubscribed, high-quality training, where demand speaks for itself without needing artificial pressure.
No post-course support. A provider that offers nothing beyond the certificate, no resource access, no way to ask follow-up questions, no professional network, is giving you less total value than the headline price suggests.
Faculty who no longer practise clinically. Training delivered exclusively by people who have moved fully into education or administration, with no current clinical caseload of their own, can drift out of touch with how a condition actually presents in a busy modern clinic. Courses led or co-led by practising specialists tend to stay closer to real-world complexity.
Doctors building genuine specialty depth rarely stop at one course, and sequencing matters as much as course selection itself. A poorly sequenced pathway can leave gaps in patient care, such as a clinician who can diagnose a condition but not manage it, or who can manage a core presentation but not its common co-occurring conditions.
The general principle is to sequence from the most fundamental, most frequently needed skill outward. In neurodevelopmental medicine, that typically means diagnosis before management, since assessment is usually the first point of patient contact, and core condition training before add-ons addressing specific populations or co-occurring conditions. Global ADHD Network's pathway, moving from the Diagnosis Course through the Management Course and on to specialist add-ons like ADHD in Women and co-occurring autism certification, reflects this logic directly.
It's also worth pacing sequencing against realistic capacity to absorb new skills. Completing multiple specialty courses in rapid succession without time to apply each one in clinic risks leaving competence shallow across the board, rather than solid in any one area. A more sustainable approach completes one course, builds genuine clinical experience applying it for several months, and only then moves to the next stage of the pathway, allowing confidence and skill to compound rather than stack thinly.
Beyond the clinical rationale, specialty course decisions have real career and financial consequences worth weighing explicitly rather than treating as an afterthought.
Specialties where patient demand currently outstrips trained clinical supply tend to offer the fastest financial return on course fees, both because newly certified clinicians can begin seeing relevant patients quickly and because assessment or treatment fees in undersupplied areas tend to be higher in private practice. Neurodevelopmental medicine is a clear current example of this pattern, with certified clinicians frequently moving into private ADHD assessment work, sometimes supported directly by a course provider's own referrals network and careers board, which shortens the gap between finishing training and seeing a first paying patient.
It's worth being realistic that this return isn't instant. Building a steady referral flow after certification typically takes several months of networking and reputation-building, regardless of specialty. Doctors who plan for that ramp-up period, rather than expecting an immediate income shift the week after course completion, make more accurate financial decisions about which courses are worth the upfront investment and when.
Finally, consider the compounding value of a well-sequenced specialty pathway over a career, rather than judging each course purely on its immediate return. A course that seems marginal in isolation can become highly valuable once combined with adjacent training, since referral volume and patient trust both tend to grow faster for clinicians who can handle a condition end to end rather than only one part of it.
It's also worth factoring in the defensive value of strong specialty training alongside its offensive, income-generating value. Doctors who can point to clear, tool-specific, guideline-aligned training when a case is later scrutinised, whether by a regulator, an indemnity provider, or a complaints process, are in a meaningfully stronger position than those relying on general clinical judgement alone. That protective value rarely shows up on a spreadsheet next to course fees, but it's frequently the more consequential return over a full career.
How do I know if a specialty course is actually worth the price being charged?Compare the depth of supervised, tool-specific practice time and the clarity of stated CPD hours against the fee, rather than comparing the fee alone against other courses. A higher-priced course with genuine hands-on practice and clear, documentable CPD hours is usually the stronger investment.
Should I prioritise cost, content, or convenience when choosing between two similar courses?Content depth should come first, since a course that doesn't build genuine competence isn't a good investment at any price or convenience level. Between two courses of comparable depth, convenience and cost are reasonable tie-breakers.
Is a longer course always better than a single-day course?Not necessarily. What matters is the proportion of time spent on genuine applied practice, not total course length. A well-structured single day with strong supervised practice, such as Global ADHD Network's Diagnosis Course, can build more real competence than a longer course padded with background lecture content.
How many CPD hours should a good specialty course provide?There's no universal number, since it depends on course depth and your annual CPD target, typically around 50 credits a year for most UK doctors. What matters more than the raw number is whether the hours are clearly stated and demonstrably tied to relevant, current clinical content.
Do I need to complete an entire specialty pathway, or can I take just one course?It depends on your caseload. Doctors handling only one part of a specialty's clinical pathway, for example diagnosis but not ongoing management, may only need the corresponding course. Doctors aiming to offer a full end-to-end service in a specialty generally benefit from completing the full pathway.
What's the biggest mistake doctors make when choosing a specialty course?Choosing based on price or marketing polish rather than an honest audit of actual clinical need and a close look at how much of the course time is genuine supervised practice versus theory delivered as a lecture.
How often should I revisit a specialty course I completed years ago?If the underlying guideline has changed meaningfully, first-line medication choices or monitoring intervals in ADHD care being a good example, it's worth checking whether a refresher or updated course is warranted, rather than assuming training completed several years ago still reflects current best practice. Many CPD schemes also expect evidence of ongoing, current learning rather than a single historic certificate.
Can I combine training from a single provider into a broader specialist certification, or do I need separate qualifications?It depends on the provider and specialty. Some providers structure related courses so that completing several in sequence builds toward a recognised combined certification, which tends to be more coherent for both the clinician and any indemnity provider reviewing training history than assembling unrelated courses from multiple, disconnected sources.
Choosing the right medical specialty course comes down to matching training deliberately to a clearly defined clinical need, then judging any specific course against accreditation currency, applied practice depth, CPD transparency, and indemnity fit, rather than price or marketing alone. Skipping the audit step is the single most common reason doctors end up with a certificate that doesn't actually change what they can safely offer patients.
For doctors weighing a move into neurodevelopmental medicine specifically, this framework points fairly directly toward a structured pathway: starting with the Diagnosis Course to build genuine DIVA-5 competency, adding the Management Course once ready to prescribe directly, and layering in add-ons like ADHD in Women or co-occurring autism certification as caseload and confidence grow. Whichever specialty you're considering, the same seven-step framework applies: know your caseload, check the guideline alignment, judge the applied practice depth, confirm the CPD hours, understand the indemnity implications, weigh cost against depth, and read reviews from clinicians whose position genuinely resembles your own.
Sources referenced: NICE Guideline NG87, CDC ADHD data, GMC guidance on CPD.
